Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0007 USD | 0.00% | 0.00% | -99.98% |
2023 | Statera Biopharma, Inc. entered into a letter of intent to acquire Worksite Labs. | CI |
2023 | Statera Biopharma, Inc.(OTCPK:STAB) dropped from S&P TMI Index | CI |
Sales 2020 | - | Sales 2021 | 1.49 2.04 | Capitalization | 73.82M 101M |
---|---|---|---|---|---|
Net income 2020 | -12M -16.43M | Net income 2021 | -102M -140M | EV / Sales 2020 * | - |
Net Debt 2020 | 1.41M 1.93M | Net Debt 2021 | 14.28M 19.55M | EV / Sales 2021 | 59,246,379 x |
P/E ratio 2020 * |
-
| P/E ratio 2021 |
-0.79
x | Employees | 46 |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
Current month | -99.98% | ||
Current year | -99.98% |
Managers | Title | Age | Since |
---|---|---|---|
Yakov Kogan
FOU | Founder | 50 | 03-06-04 |
Andrei V. Gudkov
FOU | Founder | 66 | 03-06-04 |
Michael Handley
CEO | Chief Executive Officer | 52 | 21-07-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
John A. Kallassy
BRD | Director/Board Member | 59 | 22-09-01 |
Uday Saxena
BRD | Director/Board Member | 66 | 22-06-16 |
Michael Handley
CEO | Chief Executive Officer | 52 | 21-07-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 0.0007 | 0.00% | 13,255 |
24-05-03 | 0.0007 | 0.00% | 479 |
24-05-02 | 0.0007 | +∞% | 2,711 |
24-04-30 | - | -100.00% | 51 |
24-04-29 | 0.0007 | 0.00% | 1,004 |
Delayed Quote Nasdaq, May 06, 2024 at 10:31 am
More quotes1st Jan change | Capi. | |
---|---|---|
+22.81% | 46.81B | |
+46.56% | 41.29B | |
-1.88% | 41.37B | |
-6.20% | 28.87B | |
+11.33% | 26.06B | |
-21.00% | 19.13B | |
-1.43% | 11.96B | |
+30.73% | 12.39B | |
-0.48% | 12.08B |
- Stock Market
- Equities
- STAB Stock
- STAB Stock